Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Àêóøåðñòâî è ãèíåêîëîãèÿ > Èíôåêöèè ïîëîâûõ ïóòåé è âîñïàëèòåëüíûå çàáîëåâàíèÿ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #61  
Ñòàðûé 17.09.2003, 19:38
mina mina âíå ôîðóìà
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 20.03.2003
Ñîîáùåíèé: 82
mina *
Âîäîïüÿíîâ - äåéñòâèòåëüíî â ïðîòèâî÷óìíîì åñòü òàêîé. Òàê Âû åùå ëå÷èòü íå íà÷èíàëè?
Îòâåòèòü ñ öèòèðîâàíèåì
  #62  
Ñòàðûé 25.09.2003, 10:13
mina mina âíå ôîðóìà
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 20.03.2003
Ñîîáùåíèé: 82
mina *
Óâàæàåìûé äîêòîð! Íó ÷òî æå ìíå òåïåðü äåëàòü?

Ëàáîðàòîðèÿ íå ìîæåò áûòü âèíîâàòà - ýòî îáëÑÝÑ è äåëàåò àíàëèç âðà÷ ñ áîëüøèì îïûòîì è áåñïëàòíî äëÿ ìåíÿ, ïîñêîëüêó çíàêîìûé. Äâà êóðñà àíòèáèîòèêîâ (ôðîìèëèä 7 äí â ïåðâûé ðàç è ñóìàìåä 5 äí +îôëîêñèí Ëå÷èâà 15 äíåé, èç íèõ 6 äíåé äîçîé 800 â äåíü) è öèêëîôåðîí íå ïîìîãëè.

Òåòðàöèêëèíû êàòåãîðè÷åñêè íå ðàçðåøàåò ãåïàòîëîã, õîòÿ ÏÖÐ íà ÂÃÑ óæå ïîëãîäà îòðèöàòåëüíûé.

 ïëàíàõ áåðåìåííîñòü. ×åì æå åùå ëå÷èòüñÿ [Èçîáðàæåíèÿ äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì]
Îòâåòèòü ñ öèòèðîâàíèåì
  #63  
Ñòàðûé 25.09.2003, 20:27
Zhivov Zhivov âíå ôîðóìà
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 20.08.2001
Ñîîáùåíèé: 3,792
Zhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
À â ïîñåâå óðåàïëàçìà âûäåëåíà? È ê ÷åìó îíà ÷óâñòâèòåëüíà?
Îòâåòèòü ñ öèòèðîâàíèåì
  #64  
Ñòàðûé 25.09.2003, 22:18
mina mina âíå ôîðóìà
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 20.03.2003
Ñîîáùåíèé: 82
mina *
Äàííûå ïîñåâà:

Ìèêðîáèîëîãè÷åñêîå èññëåäîâàíèå íà âàãèíàëüíûé äèñáàêòåðèîç: ëåéêîöèòû 10-12. Òðèõîìîíàäû, õëàìèäèè, ãîíîêîêêè, ìèêðîñêîì. ãðèáû - ÍÅÒ. Äàëåå óêàçàíî êîë-âî áèôèäî è ëàêòîáàêòåðèé (ëàêòî - îòñóòñòâóþò, áèôèäî - 10 â 3 ñò ïðè íîðìå îò 10 â 5 ñò) è àíàýðîáû p/Str è Fuso. Eu.
Ðåçóëüòàò: äèñáèîç, õàð-ñÿ îòñóòñòâèåì ëàêòî - è èíæåíèåì áèèäî-ôëîðû, óâåëè÷åíèåì àíàýðîáîâ.

Ìèêðîôëîðà ÷óâñòâèòåëüíà ê àçëîöèëëèíó, îôëîêñàöèíó, öåôîïåðàçîíó, öåôîòàêñèìó, êàðáåíèöèëëèíó, ìåðîïåíåìó.

ß ñïðàøèâàëà âðà÷à, ìîæíî ëè ñäåëàòü ïîñåâ êîíêðåòíî óðåàïëàçìû, îòâåò áûë îòðèöàòåëüíûé. Íåîáõîäèìî èñêàòü ìåñòî, ãäå ìîãóò ñäåëàòü èìåííî ýòîò ïîñåâ èëè ðàç âñÿ ôëîðà ÷óâñòâèòåëüíà ê âûøåïåðå÷èñëåííûì ñðåäñòâàì, òî îíè äîëæíû ïîìî÷ü? Òîãäà ïî÷åìó ìíå îôëîêñèí íå ïîìîã [Èçîáðàæåíèÿ äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì]
Îòâåòèòü ñ öèòèðîâàíèåì
  #65  
Ñòàðûé 26.09.2003, 07:09
Zhivov Zhivov âíå ôîðóìà
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 20.08.2001
Ñîîáùåíèé: 3,792
Zhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Îò ÷åãî íå ïîìîã Âàì îôëîêñèí, mina? Îò áàêòåðèàëüíîãî âàãèíîçà? Òàê è íå äîëæåí ïîìîãàòü. À ïîòîì, êòî óñòàíîâèë, ÷òî âûäåëåííàÿ ó âàñ ìèêðîôëîðà ÿâëÿåòñÿ ïðè÷èíîé íåêîåãî âîñïàëåíèÿ?  òîé ëàáîðàòîðèè âûäåëèëè àíàýðîáû? Íó î÷åíü ñîìíåâàþñü ÿ. Îò ÷åãî íå ïîìîã îôëîêñèí? Îò óðåàïëàçì? Ãäå îíè, êòî èõ ïîéìàë? ÏÖÐ???? ß óæå ïèñàë Âàì î "òî÷íîñòè" ýòîãî àíàëèçà â íàøèõ óñëîâèÿõ. Ïîéìèòå Âàñ íàäî òîëêîâî îáñëåäîâàòü. Åñëè â ìåñòíûõ ëàáîðàòîðèÿõ íå ìîãóò ñäåëàòü ïîñåâ íà óðåàïëàçìû - î ÷åì ìû âîîáùå ãîâîðèì? Ïðîñòî ãàäàåì íà êîôåéíîé ãóùå. Íå ñî÷òèòå çà ðåêëàìó, íî ÷òîáû çàêîí÷èòü âñþ ýòó îòêðâåííóþ äóðü (äðóãèõ ñëîâ íåò), ìîãó òîëüêî ïðèãëàñèòü âàñ â ñâîþ êëèíèêó. Ìîå ïðåäïîëîæåíèå, ÷òî Âû ñêîðåå âñåãî çäîðîâû è Âàì çàìîðî÷èëè ãîëîâó.
Îòâåòèòü ñ öèòèðîâàíèåì
  #66  
Ñòàðûé 27.09.2003, 11:08
mina mina âíå ôîðóìà
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 20.03.2003
Ñîîáùåíèé: 82
mina *
Äà, ïîõîæå, ÷òî ïîìûêàâøèñü åùå ïî Ðîñòîâó, ïðèäåòñÿ åõàòü â Ïèòåð èëè Ìîñêâó.... Ñåé÷àñ ñòàâëþ ñâå÷è ãèàëàêò, àöèëàêò è áèôèäóì. Ñèìïòîìû öèñòèòà (èëè óðåòðèòà?) ïîñòîÿííî ïðèñóòñòâóþò, ææåíèÿ íåò, ïðîñòî îùóùåíèå, ÷òî õî÷åòñÿ â òóàëåò ïî÷òè âñå âðåìÿ. Õî÷åòñÿ èçáàâèòüñÿ îò âñåãî ýòîãî íàêîíåö....... Äà è êîãäà íà÷íåì äåëàòü ðåáåíêà, ãäå ãàðàíòèÿ, ÷òî ýòà ïëàçìà íå ïåðåäàñòñÿ ìóæó, äà è íå ïîâëèÿåò íà áåðåìåííîñòü. Ñèë ìîèõ íåò
Îòâåòèòü ñ öèòèðîâàíèåì
  #67  
Ñòàðûé 27.09.2003, 21:06
Zhivov Zhivov âíå ôîðóìà
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 20.08.2001
Ñîîáùåíèé: 3,792
Zhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâ. mina,
Âàì áîëüøå çàíÿòüñÿ ïî æèçíè íå÷åì, êðîìå êàê ñòàâèòü ñåáå íåêèå ñâå÷è äåéñòâèå êîòîðûõ íåïîíÿòíî íèêîìó, ò.ê. àáñîëþòíî íå äîêàçàíî. Ãîëîâó òî ñåáå ìîðî÷èòü íå íàäîåëî?
Îòâåòèòü ñ öèòèðîâàíèåì
  #68  
Ñòàðûé 28.09.2003, 17:04
mina mina âíå ôîðóìà
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 20.03.2003
Ñîîáùåíèé: 82
mina *
Ïî æèçíè åñòü ÷åì çàíÿòüñÿ, äîêòîð. Áåç ïîäðîáíîñòåé.

À Âû ñ÷èòàåòå, ÷òî ôëîðó ïîñëå àíòèáèîòèêîâ íå íàäî âîññòàíàâëèâàòü, èëè íàäî, íî íå ñâå÷àìè?
Îòâåòèòü ñ öèòèðîâàíèåì
  #69  
Ñòàðûé 28.09.2003, 18:05
Zhivov Zhivov âíå ôîðóìà
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 20.08.2001
Ñîîáùåíèé: 3,792
Zhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåZhivov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íàäî áû íàâåðíîå "âîññòàíàâëèâàòü" òîãäà, êîãäà ýòè íàðóøåíèÿ ÷åòêî çàôèêñèðîâàíû è äîêàçàíî, ÷òî ýòè íàðóøåíèÿ ïðåäñòàâëÿþò íåêèé âðåä äëÿ çäîððîâüÿ ÷åëîâåêà.  ìåäèöèíå äî ñèõ ïîð îòñóòñâóþò ÷åòêèå êðèòåðèè òîãî, êîãäà ïîñëå ïðèåìà àíòèáèîòèêîâ ñëåäóåò ñ÷èòàòü ìèêðîôëîðó âëàãàëèùà "íàðóøåííîé". Âðåäíû ëè äëÿ çäîðîâüÿ ýòè "íàðóøåíèÿ" íåèçâåñòíî (ñêîðåå âñåãî íåò). Íèêòî íå äîêàçàë, ÷òî ýòè "íàðóøåíèÿ" èìåþò ìåñòî â áîëüøèíñòâå ñëó÷àåâ ïîñëå àíòèáèîòèêîòåðàïèè. Åùå áîëüøå íèêòî íå äîêàçàë, ÷òî óêàçàííûå âàìè ñðåäñòâà âîîáùå ÷òî-òî ìåíÿþò âî âëàãàëèùå è íå ïðèíîñÿò âðåä. Íè â îäíè îáùåïðèíÿòûå â ìèðå ñòàíäàðòû ëå÷åíèÿ èíôåêöèé. ïåðåäàâàåìûõ ïîëîâûì ïóòåì íå âêëþ÷åíî ïîíÿòèå "äèñáàêòåðèîç" è íè÷åãî íå ãîâîðèòñÿ î íåîáõîäèìîñòè åãî ëå÷åíèÿ. Òàê ÷òî ëó÷øå ïîñâÿòèòü ñâîå âðåìÿ (è äåíüãè) ÷åìó-íèáóäü áîëåå èíòåðåñíîìó.
Îòâåòèòü ñ öèòèðîâàíèåì
  #70  
Ñòàðûé 29.09.2003, 12:40
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad íà ôîðóìå
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,293
Ïîáëàãîäàðèëè 33,192 ðàç(à) çà 31,542 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìàÿ Ìèíà!

Ïîêà Âû â ðàçäóìüÿõ ïî êàêîìó èç ïóòåé ñëåäîâàòü (â Ïèòåð èëè ñòîëèöó - ïîëàãàþ, ÷òî ëó÷øå ê äîêòîðó Æèâîâó, ïî êðàéíåé ìåðå Âû óæå ñ íèì çíàêîìû çàî÷íî è ðóêîâîäñòâóåòñÿ îí ñîâðåìåííûìè ïîäõîäàìè â ëå÷åíèè ÈÏÏÏ), ïîçâîëüòå óòî÷íèòü/íàïîìíèòü î âåðîÿòíîé íåîáõîäèìîñòè äîîáñëåäîâàíèÿ íà ïðåäìåò æåëåçîäåôèöèòà: ñûâ. æåëåçî, ÎÆÑÑ, ôåððèòèí. Ïðè ïëàíèðîâàíèè áåðåìåííîñòè åãî äèàãíîñòèêà è ëå÷åíèå (äàæå áåç íàëè÷èÿ àíåìèè) áóäåò ñïîñîáñòâîâàòü áîëåå íîðìàëüíîìó åå òå÷åíèþ, êðîìå òîãî ÷åðåç áåëîê ëàêòîôåððèí æåëåçî ó÷àñòâóåò â ïîääåðæàíèè ëîêàëüíîãî èììóíèòåòà è êîððåêöèÿ ÆÄ ìîæåò ñïîñîáñòâîâàòü ñíèæåíèþ ÷àñòîòû ðåöèäèâîâ îòä. èíô. ïðîöåññîâ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #71  
Ñòàðûé 29.09.2003, 12:51
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad íà ôîðóìå
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,293
Ïîáëàãîäàðèëè 33,192 ðàç(à) çà 31,542 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûé Àëåêñåé!

Öèòàòà: "Îò ÷åãî íå ïîìîã Âàì îôëîêñèí? Îò áàêòåðèàëüíîãî âàãèíîçà? Òàê è íå äîëæåí ïîìîãàòü."

Ïîçâîëüòå ñ Âàìè íå ñîãëàñèòüñÿ: îôëîêñàöèí ìîæåò ïîìîãàòü ïðè ÁÂ, õîòÿ åãî ýôôåêòèâíîñòü çíà÷èòåëüíî íèæå, ÷åì ó ìåòðîíèäàçîëà.

Int J STD AIDS. 1992 May-Jun;3(3):204-7.

Comparison of ofloxacin and metronidazole for the treatment of bacterial vaginosis.

Nayagam AT, Smith MD, Ridgway GL, Allason-Jones E, Robinson AJ, Stock J.

Department of Genitourinary Medicine, University College Hospital, London.

The efficacy and safety of ofloxacin, 200 mg twice daily for 7 days, was compared with metronidazole, 400 mg twice daily for 7 days, for the treatment of bacterial vaginosis (BV). Diagnosis of BV was confirmed by at least 3 of the following 4 criteria: the presence of an abnormal vaginal discharge on examination, clue cells on microscopy of vaginal specimens, vaginal pH greater than 5.0 and a positive amine test. Vaginal specimens were examined for Mobiluncus spp, analysed for the succinate/lactate (S/L) ratio and cultured for Trichomonas vaginalis, Gardnerella vaginalis, Bacteroides spp. and Mycoplasma hominis. Patients were reviewed on completion of treatment (visit 2) and 14 days later (visit 3). The diagnosis of BV was accepted in 119 of 149 patients recruited, 60 of whom received treatment with ofloxacin and 59 received metronidazole. Sixty-two patients, 31 in each treatment group, completed the study. Diagnostic cure at visit 2 was significantly better in the metronidazole group with cure rates of 56% (metronidazole) vs 23% (ofloxacin) (P = 0.001); this was associated with higher eradication rates for G. vaginalis (100% vs 56%) and Bacteroides spp. (97% vs 49%). There were no significant differences between the two groups in clinical cure at either visit 2 or 3 or in diagnostic cure at visit 3. Both treatments were well tolerated. We conclude that metronidazole is likely to remain the first choice of treatment for BV but ofloxacin offers a safe and effective alternative.

Randomized Controlled Trial


Sex Transm Dis. 1993 Sep-Oct;20(5):262-4.

Comparative evaluation of ofloxacin and metronidazole in the treatment of bacterial vaginosis.

Covino JM, Black JR, Cummings M, Zwickl B, McCormack WM.

Department of Medicine, State University of New York Health Science Center at Brooklyn 11203.

BACKGROUND AND OBJECTIVES: The epidemiology and etiology of bacterial vaginosis is poorly understood. Many antimicrobial agents have been studied and suggested as treatment alternatives for this infection. Fluoroquinolones have in vitro activity against some of the organisms associated with bacterial vaginosis and may provide another treatment option. STUDY DESIGN: Women who presented with symptomatic bacterial vaginosis were randomly assigned to receive either oral ofloxacin 300 mg twice a day or oral metronidazole 500 mg twice a day for seven days. Twenty-seven of the 31 patients who were enrolled in this double-blinded study were evaluable. RESULTS: Fourteen women received ofloxacin. At follow-up, four had no residual symptoms, seven noted a reduction in symptoms, and three had no change in symptoms. Eight (57%) of the 14 women who received ofloxacin had secretions at follow-up that satisfied the criteria for the diagnosis of bacterial vaginosis. Thirteen women received metronidazole. Nine had no residual symptoms and four noted a reduction in symptoms. Eleven (85%) of the 13 women had normal vaginal secretions and two (15%) had secretions that were improved. None of the women who received metronidazole had secretions at follow-up that met the criteria for the diagnosis of bacterial vaginosis. CONCLUSION: We conclude that ofloxacin is less effective than metronidazole in the treatment of bacterial vaginosis.

Multicenter Study
Randomized Controlled Trial
Îòâåòèòü ñ öèòèðîâàíèåì
  #72  
Ñòàðûé 29.09.2003, 19:38
mina mina âíå ôîðóìà
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 20.03.2003
Ñîîáùåíèé: 82
mina *
Óâàæïåìûé äîêòîð Vad,

Ñïàñèáî çà ñîâåò. Ìíå êàæåòñÿ, ãåïàòîëîã ìíå ãîâîðèëà, ÷òî íåëüçÿ òåì, êòî èìååò ãåïàòèò Ñ, ÷òîáû áûëî âûñîêîå æåëåçî. Òàê ÷òî, íàâåðíî, êîððåêòèðîâàòü åãî, åñëè îíî áóäåò íèçêîå, âñå ðàâíî íåëüçÿ áóäåò....

Îñòàëîñü ìíå, íàâåðíîå, òîëüêî ýðèòðîìèöèí ïîïðîáîâàòü, ÷òîáû ïëàçìó óáèòü, êàê Âû äóìàåòå?
Îòâåòèòü ñ öèòèðîâàíèåì
  #73  
Ñòàðûé 29.09.2003, 20:25
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad íà ôîðóìå
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,293
Ïîáëàãîäàðèëè 33,192 ðàç(à) çà 31,542 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìàÿ Ìèíà!

Íå ðåêîìåíäóåòñÿ, ÷òî áû çàïàñû æåëåçà â ïå÷åíè áûëè âûñîêèå, òå ôåððèòèí êðîâè áûë ñâûøå 50-60 ìêã/ë. ß æå âåäó ðå÷ü î òêàíåâîì ñîäåðæàíèè æåëåçà, êîãäà ôåððèòèí ìåíåå 15-20 ìêã è ñîîòíîøåíèå Få/ÎÆÑÑ ìåíåå 15-20%.

Î êàêîé äîçå è ïðîäîëæèòåëüíîñòè èäåò ðå÷ü îòíîñèòåëüíî ýðèòðîìèöèíà?, ìàëîâåðîÿòíî, ÷òî ïîñëå àçèòðîìèöèíà ýðèòðîìèöèí ìîæåò ïîìî÷ü.

Ìîæåò èìååò ñìûñë ïîïðèíèìàòü êëþêâåííûé ýêñòðàêò/ñîê? Ñîãëàñíî íåäàâíèì àìåðèêàíñêèì ðåêîìåíäàöèÿì:

Curr Urol Rep. 2003 Oct;4(5):399-403.
Recurrent urinary tract infection in women: emerging concepts regarding etiology and treatment considerations.

Gormley EA.

Dartmouth-Hitchcock Medical Center, Section of Urology, One Medical Center Drive, Lebanon, NH 03756, USA.

Recurrent urinary tract infections are caused by a combination of host factors and bacterial virulence. The patient with symptoms suggestive of recurrent urinary tract infections benefits from cultures to confirm the diagnosis of recurrent infections. The community also benefits because they allow for the tracking of resistant patterns. Once a patient has been diagnosed with recurrent urinary tract infections, there are a number of treatment choices in terms of initial treatment and prophylaxis. Treatment of the acute infection should follow the published guidelines of the Infectious Diseases Society of America taking into account local patterns of resistance. Younger patients can prevent infections by avoiding spermicides and taking cranberry tablets. Older patients may prevent infections by using estrogen and emptying their bladders fully. All patients may benefit from using antibiotic prophylaxis.


Infect Dis Clin North Am. 2003 Jun;17(2):457-71.

Novel approaches to prevention of urinary tract infections.

Stapleton A.

Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, 1959 NE Pacific Avenue, Box 356523, Seattle, WA 98195, USA. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Urinary tract infections are common clinical entities occurring in a variety of patient groups, most frequently caused by uropathogenic E. coli. Novel methods of preventing UTI currently under development are focused on three key approaches: (1) use of cranberry products, (2) restoration of the normal flora using Lactobacillus-based probiotic preparations, and (3) vaccine development. Although promising studies in each of these areas have been published or are ongoing, additional properly designed and powered clinical studies based on solid scientific evidence are needed.
Îòâåòèòü ñ öèòèðîâàíèåì
  #74  
Ñòàðûé 30.09.2003, 20:49
mina mina âíå ôîðóìà
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 20.03.2003
Ñîîáùåíèé: 82
mina *
Ïðî ýðèòðîìèöèí äóìàëà 10 äíåé ïî 3 òàáëåòêè â äåíü, íî ðàç íå ïîìîæåò ïîñëå àçèòðîìèöèíà, ìîæåò òîãäà ôðîìèëèä çàíîâî, òîëüêî 14 äíåé? Ïðîøëûé ðàç, êîãäà ÿ ïèëà 7 äíåé, ìíå êàæåòñÿ, áûëî ìåíüøå öèñòèòíûõ ñèïòîìîâ ê 7 äíþ..

Êëþêâåííûé ñîê áóäó ïèòü îáÿçàòåëüíî, ñïàñèáî çà ïîäñêàçêó è ññûëêè.
Ñ ïàðòíåðîì ÿ íå æèâó âñå âðåìÿ, ïîêà ëå÷óñü, òàê ÷òî ïîâòîðíîå çàðàæåíèå èñêëþ÷åíî, ïðîñòî âèäíî ïëàçìà ìîÿ ðåçèñòåíòíàÿ ïîïàëàñü, èëè ñëèøêîì äàâíî îíà ó ìåíÿ, èëè òàáëåòêè ïîääåëüíûå áûëè. Èùó ñåé÷àñ ìåñòî â Ðîñòîâå, ãäå ìîæíî êîíêðåòíî åå ïîñåÿòü è âûÿñíèòü ÷óâñòâèòåëüíîñòü è ãäå áåðóò êðîâü íà ôåððèòèí è ÎÆÑÑ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #75  
Ñòàðûé 01.10.2003, 12:14
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad íà ôîðóìå
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,293
Ïîáëàãîäàðèëè 33,192 ðàç(à) çà 31,542 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìàÿ Ìèíà!

Âñå òàê, åñëè â êàæäîé òàáëåòêå ñîäåðæèòñÿ 0,5 ãðàììà, áîëüøå ÷òî ëèáî òðóäíî ìíå ðåêîìåíäîâàòü êàê íå ñïåöèàëèñòó. Ïî æåëåçó: ñûâîðîòî÷íîå æåëåçî, ÎÆÑÑ è åñëè íàéäåòå ôåððèòèí. Åñëè Âàì íå ñëîæíî, òî íàïèøèòå ìíå íà ìåéë [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ], òîãäà ñìîãó ïîäñêàçàòü îäíîãî âðà÷à, íà ìîé âçãëÿä âåñüìà îïûòíîãî è çàíèìàþùåãîñÿ ëå÷åíèåì óðåàïëàçìîçà â Ðîñòîâå-íà-Äîíó, òê íà ôîðóìå çàïðåùåíà ïðÿìàÿ ðåêëàìà. Òàêæå îí îñòàâèë è êîíòàêòíûé òåëåôîí è Âû ñàìè ïðè ëè÷íîì îáùåíèè ðåøèòå î ñòåïåíè ñâîåãî äîâåðèÿ ê íåìó.

Ñêîðåéøåãî âûçäîðîâëåíèÿ.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 16:19.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.